STOCK TITAN

Elutia (NASDAQ: ELUT) director receives 106,393 stock options at $0.96 strike

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

ELUTIA INC. director Guido J. Neels received a grant of stock options covering 106,393 shares of Class A common stock. The options have an exercise price of $0.96 per share and expire on June 11, 2036.

The grant was made automatically under the company’s Non-Employee Director Compensation Program. These options vest and become exercisable on the earlier of the day immediately preceding the company’s first annual meeting following the grant date or the first anniversary of the grant date, if he continues serving on the board.

Positive

  • None.

Negative

  • None.
Insider NEELS GUIDO J
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 106,393 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 106,393 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Options granted 106,393 options Stock Option (Right to Buy) granted to director on June 11, 2026
Exercise price $0.96 per share Exercise price for options on Class A Common Stock
Underlying shares 106,393 shares Class A Common Stock underlying granted options
Options after grant 106,393 options Total derivative securities following transaction, held directly
Expiration date June 11, 2036 Option expiration under Non-Employee Director Compensation Program
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Class A Common Stock financial
"underlying_security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Non-Employee Director Compensation Program financial
"granted automatically under the Issuer's Non-Employee Director Compensation Program"
vests and becomes exercisable financial
"vests and becomes exercisable on the earlier of (i) the day immediately preceding"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
NEELS GUIDO J

(Last)(First)(Middle)
20 FIRSTFIELD ROAD

(Street)
GAITHERSBURG MARYLAND 20878

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ELUTIA INC. [ ELUT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$0.9606/11/2026A106,393 (1)06/11/2036Class A Common Stock106,393$0106,393D
Explanation of Responses:
1. This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date.
/s/ Jeffrey Hamet, Attorney-in-Fact for Guido Neels06/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ELUT (ELUTIA INC.) report for Guido J. Neels?

ELUTIA INC. reported that director Guido J. Neels received a grant of 106,393 stock options. These options give him the right to buy Class A common shares at a fixed price, as part of the company’s Non-Employee Director Compensation Program.

How many ELUTIA INC. options were granted to director Guido J. Neels and at what price?

Guido J. Neels was granted 106,393 stock options with an exercise price of $0.96 per share. This means he can later buy up to 106,393 Class A common shares at $0.96, regardless of the market price at exercise.

When do Guido J. Neels’s ELUT (ELUTIA INC.) stock options vest?

The options vest on the earlier of the day immediately before ELUTIA INC.’s first annual meeting after the grant or the first anniversary of the grant date. Vesting is conditioned on Neels continuing to serve on the board until that date.

What is the expiration date of the ELUTIA INC. stock options granted to Guido J. Neels?

The stock options granted to Guido J. Neels expire on June 11, 2036. After that date, any unexercised options become worthless, so he must exercise vested options before expiration to buy shares at the $0.96 exercise price.

Is the ELUTIA INC. option grant to Guido J. Neels a market purchase or compensation award?

The transaction is a compensation award, not a market purchase. The filing classifies it as a grant or award acquisition, automatically granted under the Non-Employee Director Compensation Program, with no cash paid at grant and a fixed $0.96 exercise price.